# US 2021/0275726 A1 · Methods of synthesis for a thioketal diol

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275726 A1
- Document ID: US20210275726A1
- Status: Published application
- Kind: A1
- Application number: 17/328,531
- Filed: 2021-05-24
- Published: 2021-09-09
- Earliest claimed: 2019-02-20
- Assignees: Warsaw Orthopedic, Inc.
- Applicants: Warsaw Orthopedic, Inc.
- Inventors: Roger E. Harrington; Jerbrena C. Jacobs; Robert Doyle
- Web page: https://patentgrep.com/patent/US20210275726A1

## CPC

- A61L 27/58: Materials at least partially resorbable by the body
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/40: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L 27/446: {with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46}
- A61L 27/46: with phosphorus-containing inorganic fillers
- C07C 319/20: by reactions not involving the formation of sulfide groups
- C08G 18/18: containing secondary or tertiary amines or salts thereof
- C08G 18/244: {tin salts of carboxylic acids}
- C08G 18/246: {containing also tin-carbon bonds}
- C08G 18/3868: {the sulfur atom belonging to a sulfide group}
- C08G 18/72: Polyisocyanates or polyisothiocyanates
- A61L 2300/40: characterised by a specific therapeutic activity or mode of action
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/38: for reconstruction of the spine, vertebrae or intervertebral discs
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS

## Abstract

A method of making a hydroxyl-terminated thioketal diol is provided, the method comprising reacting a thioketal ester with a non-pyrophoric reducing agent to form a hydroxyl-terminated thioketal diol. The hydroxyl-terminated thioketal diol can be 2,2-(propane-2,2-diylbis(sulfanediyl)) diethanol. The non-pyrophoric reducing agent can be a sodium aluminum hydride, for example, sodium bis (2-methoxyethoxy)aluminum hydride. The thioketal ester can be dimethyl 2,2-(propane-2,2-diylbis(sulfanediyl)) diacetate. A biodegradable matrix prepared by reacting a hydroxyl-terminated thioketal diol with an isocyanate is provided. A method of making a biodegradable polyurethane composite is also provided.

## Claims

### Claim at position 1

1-13. (canceled)

### Claim 14

A method of making a biodegradable polyurethane composite, the method comprising reacting a hydroxyl-terminated thioketal diol with an isocyanate and a reinforcement material to form the biodegradable polyurethane composite, wherein the hydroxyl-terminated thioketal diol is prepared by reacting a thioketal diester with a non-pyrophoric reducing agent to form the hydroxyl-terminated thioketal diol, and the isocyanate is a lysine diisocyanate.

### Claim 15 (depends on 14)

The method of claim 14, wherein the reacting comprises mixing the hydroxyl-terminated thioketal diol with the isocyanate to form a mixture; and mixing the mixture with the reinforcement material to form the biodegradable polyurethane composite.

### Claim 16 (depends on 14)

The method of claim 14, wherein the mixture comprises crosslinked polyurethane.

### Claim 17 (depends on 14)

The method of claim 14, wherein the reacting comprises exposing the thioketal diol, the lysine diisocyanate and the reinforcement material to a catalyst.

### Claim 18 (depends on 17)

The method of claim 17, wherein the catalyst comprises (i) an amine or an organometallic compound; (ii) triethylene diamine, bis(dimethylaminoethyl)ether or dimethylethanolamine; (iii) stannous octoate or dibutyltin laurate; or (iv) iron (III) acetyl acetatonate.

### Claim 19 (depends on 14)

The method of claim 14, wherein the reinforcement material comprises calcium carbonate, calcium sulfate, calcium phosphosilicate, sodium phosphate, calcium aluminate, calcium phosphate, calcium carbonate, hydroxyapatite, demineralized bone, mineralized bone, or combinations thereof.

### Claim 20 (depends on 14)

The method of claim 14, further comprising adding a bioactive agent to the polyurethane composite.

### Claim 21

A method of making a biodegradable polyurethane composite, the method comprising reacting a thioketal ester with a non-pyrophoric reducing agent to form a hydroxyl-terminated thioketal diol; and reacting the hydroxyl-terminated thioketal diol with a polyisocyanate to form a biodegradable matrix.

### Claim 22 (depends on 21)

The method of claim 21, wherein the hydroxyl-terminated thioketal diol comprises 2,2-(propane-2,2-diylbis(sulfanediyl)) diethanol.

### Claim 23 (depends on 21)

The method of claim 21, wherein the non-pyrophoric reducing agent comprises (i) sodium aluminum hydride, or (ii) sodium bis (2-methoxyethoxy)aluminum hydride.

### Claim 24 (depends on 21)

The method of claim 21, wherein the thioketal ester is dimethyl 2,2-(propane-2,2-diylbis(sulfanediyl)) diacetate.

### Claim 25 (depends on 21)

The method of claim 21, wherein the thioketal ester is prepared by reacting a thioglycolic acetate with a methoxy functional compound in the presence of bismuth (III) chloride.

### Claim 26 (depends on 25)

The method of claim 25, wherein the thioglycolic acetate is methyl 2-mercaptoacetate.

### Claim 27 (depends on 25)

The method of claim 25, wherein the methoxy functional compound is 2,2-dimethoxypropane.

### Claim 28

A method of making a biodegradable polyurethane composite using a hydroxyl terminated thioketal of formula I:
wherein R1 and R2 are independently CH2C(O)OCH3 or CH2CH2OH; and
R3 and R4 are independently CH3, CH2CH3, (CH2)2CH3 or (CH2)3CH3, the method comprising: (i) reacting a thioglycolic acetate with a methoxy functional compound in the presence of bismuth (III) chloride to obtain a thioketal ester when R1 and R2 are both CH2C(O)OCH3; (ii) reacting the thioketal ester with a non-pyrophoric reducing agent to form a hydroxyl-terminated thioketal diol when R1 and R2 are both CH2CH2OH; and (iii) reacting the hydroxyl-terminated thioketal diol with a polyisocyanate.

### Claim 29 (depends on 28)

The method of claim 28, wherein (i) the thioglycolic acetate is methyl 2-mercaptoacetate, the methoxy functional compound is 2,2-dimethoxypropane; (ii) the reducing agent is a sodium aluminum hydride and (iii) the thioketal ester is dimethyl 2,2-(propane-2,2-diylbis(sulfanediyl)) diacetate.

### Claim 30 (depends on 21)

The method of claim 21, wherein the hydroxyl-terminated thioketal diol is reacted with the polyisocyanate and a reinforcement material to form the biodegradable polyurethane composite.

### Claim 31 (depends on 30)

The method of claim 30, wherein the reinforcement material comprises (i) a bone or bone substitutes; or (ii) calcium carbonate, calcium sulfate, calcium phosphosilicate, sodium phosphate, calcium aluminate, calcium phosphate, calcium carbonate, hydroxyapatite, demineralized bone, mineralized bone, or combinations or modified forms thereof.

### Claim 32 (depends on 21)

The method of claim 21, wherein the polyisocyanate comprises lysine diisocyanate, lysine triisocyanate, toluene diisocyanate, arginine diisocyanate, asparagine diisocyanate, glutamine diisocyanate, hexamethylene diisocyanate, hexane diisocyanate, methylene bis-p-phenyl diisocyanate, isocyanurate polyisocyanates, 1,4-butane diisocyanate, uretdione polyisocyanate, or aliphatic, alicyclic, or aromatic polyisocyanates.

### Claim 33 (depends on 21)

The method of claim 21, further comprising a bioactive agent.
